VIVUS To Present At Four Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at four investment conferences during the months of April and May 2013.

The conference presentation schedule is as follows:
Needham 12th Annual Healthcare Conference
April 30, 2013, 1:40pm EDT
Westin Grand Central Hotel
New York, NY
 
Bank of America Merrill Lynch 2013 Health Care Conference
May 15, 2013, 4:20pm PDT
Encore at the Wynn
Las Vegas, NV
 
BioEquity Europe 2013
May 23, 2013, 10:30am CEST
Sheraton Hotel
Stockholm, Sweden
 
Deutsche Bank 38th Annual dbAccess Health Care Conference
May 30, 2013, 3:30pm EDT
Westin Boston Waterfront Hotel
Boston, MA

A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com .

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com .

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.         Timothy E. Morris         Chief Financial Officer         morris@vivus.com                  Financial Media Relations:         Joele Frank, Wilkinson Brimmer Katcher         Jennifer Beugelmans         jbeugelmans@joelefrank.com         (212) 895-8692                  Investor Relations:         The Trout Group         Brian Korb         bkorb@troutgroup.com         646-378-2923